跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
瑞唯抒 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Teduglutide for Injection
Approved
生物制品
Teduglutide for Injection
TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BRANCH
🇨🇳 National Medical Products Administration
Approval Date
Feb 20, 2024
Approval ID
8Xx2hEQ87LX
Company
TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BRANCH
Type
生物制品
Approval Details
Approval Id
8Xx2hEQ87LX
Approval Number
国药准字SJ20240008
Generic Name
注射用替度格鲁肽
Generic Name En
Teduglutide for Injection
Trade Name
瑞唯抒
Drug Type
生物制品
Dosage Form
注射剂
Strength
5mg/瓶
Reg Date
2024-02-20
Expired Date
2029-02-19
Company Name
TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BRANCH
Production Company Name
PATHEON ITALIA SPA
Company Detail Path
/organization/takeda-pharmaceuticals-international-ag-ireland-branch
Production Company Detail Path
/organization/patheon-italia-spa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 20, 2024
Approval ID
8Xx2hEQ87LX
Type
生物制品
Back to NMPA Approvals